Europe
Health
Female CEOs

Mylan

$18.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-0.28%) Today
+$0.00 (0.00%) As of 5:30 PM EDT after-hours

Why Robinhood?

You can buy or sell Mylan and other stocks, options, ETFs, and crypto commission-free!

About MYL

Mylan N.V. Ordinary Shares, also called Mylan, is a pharmaceutical healthcare company. Read More The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.

Employees
35,000
Headquarters
Hatfield, Hertfordshire
Founded
2014
Market Cap
9.35B
Price-Earnings Ratio
39.35
Dividend Yield
0.00
Average Volume
5.74M
High Today
$18.23
Low Today
$17.77
Open Price
$18.14
Volume
4.20M
52 Week High
$39.59
52 Week Low
$16.63

Collections

Europe
Health
Female CEOs
Pharmaceutical
UK
Technology
Manufacturing

MYL News

ReutersJul 19

Health Canada to keep importing Kaleo's epinephrine shot amid shortages

356
BloombergJul 10

‘There’s Nothing to Give Them’: The Hunt for Lifesaving Epipens

85
ReutersJul 10

Amneal Pharma cuts core profit forecast on allergy shot supply issues

590

MYL Earnings

$0.80
$1.01
$1.22
$1.43
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, Pre-Market

More MYL News

ReutersJul 9

Novartis to sell epinephrine shot in U.S. pharmacies amid EpiPen shortage

354
ReutersJul 9

Novartis launches Adamis allergy shots in U.S. pharmacies amid EpiPen shortage

144
ReutersJul 1

Mylan seeks dismissal of Sanofi's EpiPen antitrust lawsuit

243
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.